Stay updated on PCSK9 Inhibitors in HoFH Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.
Latest updates to the PCSK9 Inhibitors in HoFH Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRecord History page shows a new Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe revision history shows a new entry Revision: v3.3.2 and removes Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check43 days agoChange DetectedRevision: v3.3.1 was added and revision: v3.2.0 was removed in the page history.SummaryDifference0.1%
- Check50 days agoChange DetectedRemoval of the funding notice banner; the trial record and its history are unchanged.SummaryDifference0.8%
- Check64 days agoChange DetectedVersion 2 (2021-08-24) updates the Recruitment Status for NCT04759534. The record history shows a change in the study's recruitment status.SummaryDifference0.1%
- Check93 days agoChange DetectedUpdated operating status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference13%
Stay in the know with updates to PCSK9 Inhibitors in HoFH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.